Vivos Therapeutics, Inc.
VVOS
$2.10
-$0.04-1.64%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -5.40M | -5.01M | -3.86M | -2.83M | -2.62M |
| Total Depreciation and Amortization | 384.00K | 306.00K | 177.00K | 144.00K | 146.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 55.00K | 342.00K | 317.00K | 62.00K | 148.00K |
| Change in Net Operating Assets | 799.00K | 871.00K | -426.00K | -319.00K | -1.86M |
| Cash from Operations | -4.16M | -3.49M | -3.80M | -2.94M | -4.19M |
| Capital Expenditure | 83.00K | -771.00K | -122.00K | -165.00K | -192.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 0.00 | -5.14M | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 83.00K | -5.91M | -122.00K | -165.00K | -192.00K |
| Total Debt Issued | -417.00K | 9.64M | -- | -- | -- |
| Total Debt Repaid | -17.00K | -- | -- | -- | -- |
| Issuance of Common Stock | 3.29M | 2.66M | -- | 3.50M | 4.30M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -97.00K | -837.00K | -- | -446.00K | -509.00K |
| Cash from Financing | 2.76M | 11.46M | -- | 3.05M | 3.79M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.32M | 2.06M | -3.92M | -51.00K | -592.00K |